Data for the paper: ‘Effects of different factors on the efficacy of anti PD-(L)1 monotherapy in patients with advanced non-small cell lung cancer: An observational, retrospective cohort study’
DOI: 10.4121/19606378
Datacite citation style
Dataset
Effects of sex, age, EGFR mutation status and smoking status on immunotherapy. we showed that the benefits for PFS and OS were similar in male and female, and in younger (< 65 years of age) and older (≥65 years of age) patients. EGFR mutation status and smoking status are two independent influencing factors. Regardless of EGFR mutation status, the ORR and PFS of current-smokers were better than those of never-smokers; The benefits of immunotherapy for other mutant subtypes except 19del, L858R and T790M were similar to those of EGFR wild-type; Former-smokers are a unique population who benefit poor from immunotherapy than never-smokers or current-smokers.
History
- 2022-04-20 first online, published, posted
Publisher
4TU.ResearchDataFormat
Table/excel Figure/PDFReferences
Funding
- This work was supported by grants B2021348 from the Guangdong Medical Research Foundation and 1202101004 from the President Foundation of Integrated Hospital of Traditional Chinese Medicine, Southern Medical University.
Organizations
Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University.DATA
Files (6)
- 233,100 bytesMD5:
c89cc5428f1f46cecb4eccd2d033d2b8Figure 1 Case inclusion process.pdf - 2,134,571 bytesMD5:
076943bf5e1fbfea99a6d8e7c8451f61Figure2.A-J.pdf - 2,179,481 bytesMD5:
7af6ded3ac5dccf6eebb53fa1eaa90abFigure3.A-D.pdf - 12,253 bytesMD5:
8ac704be316743791578c29a3aefb776Table 1- Baseline Characteristics.xlsx - 12,228 bytesMD5:
ddc570b47d86a1bace0f9b597811c548Table 2- Univariable and Multivariable Analysis.xlsx - 11,002 bytesMD5:
3e9fdf0f28f4235f2b76b48ff130bdf0Table 3- Clinical benefit.xlsx -
download all files (zip)
4,582,635 bytes unzipped




